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Cervical intraepithelial neoplasia in lymphoma patients: a cytological
and colposcopic study
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of Haematology, Royal Infirmary, Lauriston Place, Edinburgh EH3 9YW, UK.
Summary Twenty-seven patients with Hodgkin's (n=19) and non-Hodgkin's (n=8) lymphomas underwent
cytological and colposcopic screening of the uterine cervix. Colposcopically directed cervical punch biopsies
were taken from all patients in whom a colposlopic abnormality was detected. Lymphoma patients were
compared with 79 controls with normal cervical cytology and no known haematological abnormality.
Colposcopically directed punch biopsies were taken from the cervical transformation zone of all controls.
Significantly more lymphoma patients (19%) than controls (3%) had CIN II or III (P<0.01) and cervical
human papillomavirus infection, as judged by the presence of koilocytes (52% of lymphoma patients; 27% of
controls; P<0.02). All six lymphoma patients with CIN had Hodgkin's disease (HD), and five had received
combination chemotherapy. Half of the cases of CIN in lymphoma patients and all the cases of CIN in
control patients were not detected by cervical cytology. This study suggests that female patients with HD are
at increased risk of CIN, and that cervical cytology alone may be an inadequate form of screening for these
patients.
Patients with lymphomas are known to be at increased risk
of developing second malignancies, especially acute myeloid
leukaemia (Coleman et al., 1982; Tester et al., 1984) and, in
the case of patients with Hodgkin's disease (HD), non-
Hodgkin's lymphomas (Jacquillat et al., 1984). It has been
suggested that the incidence of second malignancies in HD
patients correlates with the level of treatment to which
patients are exposed (Arseneau et al., 1972), and, for those
receiving very intensive chemotherapy and radiotherapy, the
risk may increase by as much as 1,500 times (Coleman et al.,
1982; Tester et al., 1984). There is little evidence of an
increased incidence of second malignancies in patients
treated with radiotherapy alone leading some authors to
postulate that the increase in risk is related to the use of
chemotherapeutic agents, especially alkylating agents
(Anonymous, 1985b). These drugs are mutagenic and carci-
nogenic in laboratory systems and are also immunosuppres-
sive (Schilsky & Erlichman, 1982). Procarbazine, an
important drug in the treatment of HD, is also highly
carcinogenic in experimental systems (Schilsky & Erlichman,
1982).
Patients with HD also suffer from an increased incidence
of viral infections, including warts (Morison, 1975), and this
is believed to be due to alterations in immune function
(Kumar & Penny, 1982). Defects in cell-mediated immunity
are seen much more commonly than defects in humoral
immunity in untreated HD, and in HD patients in remission
after treatment (Kumar & Penny, 1982; Bergmann et al.,
1987). Alterations in cell-mediated and humoral immunity
tend to be seen only in advanced disease in non-Hodgkin's
lymphomas (Kumar & Penny, 1982).
Cell-mediated immunity is believed to be more important
than humoral immunity in mediating immunosurveillance
against tumours (Streilein, 1978). Second malignancies may,
therefore, develop in HD patients due to a primary defect in
immunosurveillance rather than as a consequence of
chemotherapy.
Although cervical neoplasia is reported to be increased in
incidence in other immunosuppressed patients such as renal
transplant recipients (Porreco et al., 1975), the co-existence
of this disease with lymphomas has previously been des-
cribed only in the form of isolated case reports (Shokri-
Tabibzadeh et al., 1981; Sillman et al., 1984).
In this study we examined a defined group of patients
suffering from HD or non-Hodgkin's lymphoma in an
attempt to discover their relative risk of developing cervical
neoplasia. We also looked for evidence of cervical human
papillomavirus (HPV) infection in these patients, in view of
the continuing debate concerning the role of this virus in
cervical malignancy (Anonymous, 1985a). There is some
Table I Patients' characteristics
Mean Mean age of Median no. Current combined oral
age Number coitarche sexual partners Current smokers contraceptive pill use
(range) parous (%) (range) (range) (%) (%)
All lymphoma
patients 38.9 18 (67) 21.2 1 6 (22) 6 (22)
(n=27) (24-59) (13-40) (1-30)
HD 36.5 10 (53) 21.1 1 2 (11) 4 (21)
(n= 19) (24-59) (16-40) (1-9)
Non-HD 44.5 8 (100) 21.5 1 4 (50) 2 (25)
(n =8) (29-56) (13-33) (1-30)
Control patients 39 71 (90) 19 2 37 (47) 37 (24)
(n=79) (20-71) (14-27) (1-6)
n=number of patients.
Correspondence: R.G. Hughes, Ward 34, Royal Infirmary, Lauris-
ton Place, Edinburgh EH3 9YW, UK.
Received 26 February 1988; and in revised form, 17 November 1988.
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evidence that immunosuppression may lead to the malignant
conversion of papillomavirus induced lesions in animals
(Campo & Jarrett, 1987) and in man (Sillman et al., 1984;
Rudlinger et al., 1986; Schneider et al., 1983).
Patients and methods
A group of 45 female patients attending the Department of
Haematology, Royal Infirmary, Edinburgh, was invited to
participate in the present study. They were all diagnosed as
suffering from Hodgkin's or non-Hodgkin's lymphomas and
are described throughout the paper as 'lymphoma patients'.
All had been sexually active in the past or at present, and
were between the ages of 16 and 60. Twenty-seven agreed to
take part in the study. Ten patients did not wish to
participate and eight were excluded for other reasons: five
having undergone total abdominal hysterectomy, one being
pregnant and two living out of Edinburgh.
Lymphoma patients were compared with 79 controls.
These were patients admitted to the gynaecological wards to
undergo an unrelated minor gynaecological procedure such
as dilatation and curettage or laparoscopic sterilisation. They
had never had a suspicious cervical smear and had had a
normal (n=73) or an inflammatory (n=6) smear within the
preceding three years. Informed consent for colposcopy and
cervical punch biopsy was obtained. A full reproductive,
sexual, contraceptive, smoking, gynaecological and cervical
smear history was taken from all patients and controls. If
patients reported having had previous cervical smears, these
were traced and reviewed by M.C. Cervical smears were
taken from all patients by M.C. or R.H. using an Ayres
spatula. They were fixed immediately in methylated spirit (74
O.P.), processed routinely and read by M.C. Smears were
graded according to the standard Lothian area classification
as follows: 0, unsatisfactory; 1, normal: 1+, inflammatory
changes bordering on mild dyskaryosis; 2, dyskaryosis con-
sistent with CIN grade I or II; 3, malignant cells seen,
consistent with CIN III or invasive carcinoma. Koilocytes
(Meisels & Fortin, 1976) were reported if present.
Patients and controls underwent full colposcopic examin-
ation by R.H. or M.A. Cervical punch biopsies were taken
from patients only if a colposcopic abnormality was visual-
ised and from all controls, and were fixed immediately in
Bouin's solution for routine histopathological assessment.
Cervical intraepithelial neoplasia (CIN) was graded accord-
ing to recognised criteria (Buckley et al., 1982) and koilocy-
tosis was reported, if present.
Results
General patient data
It can be seen from Table I that the lymphoma patients
studied were less likely to have ever been pregnant and
reported a later onset of sexual activity and fewer sexual
partners than the control patients with normal cervical
cytology. In addition, fewer of the lymphoma patients
smoked.
Haematological data
Details of haematological diagnoses and chemotherapeutic
agents used are given in Table II. Standard dosage regimes
were employed.
The patients who received both radiotherapy and chemo-
therapy did so because of either residual disease or relapse
after radiotherapy. There were two exceptions: patient no. 9
was given radiotherapy when she experienced a relapse
following initial chemotherapy and patient no. 6 experienced
profound myelosuppression during chemotherapy, necessitat-
ing the completion of her treatment with radiotherapy.
Patients with localised disease (stage 1 and sometimes
stage 2) were given radiotherapy and only one patient (no.
27) received pelvic radiotherapy. Chemotherapy was the
treatment of choice for more extensive disease. In non-
Hodgkin's lymphomas the degree of differentiation was also
considered; thus patients with low grade lymphomas received
radiotherapy and those with higher grade tumours chemo-
therapy. In general, therefore, those patients who received
chemotherapy had more extensive and/or less differentiated
tumours than those who received radiotherapy.
Previous cervical cytology
Twenty-one (78%) lymphoma patients (including four with
CIN) had previously had completely normal cervical cyto-
logy. Smears from 15 of these patients could be traced and
were confirmed as being normal. One (from a patient found
to have CIN III) which had previously been described as
'class 1 inflammatory' was reclassified as class 2. The mean
length of time since the last normal smear for the whole
group was 67.3 months (range 5-240) and for the patients
found to have CIN 16.3 months (6-45 months).
One patient (no. 16) had had a class 1 + smear 4 months
before being seen at the colposcopy clinic. This cytological
grading was confirmed on review, and a diagnosis of CIN I
with koilocytosis was made by histological examination of a
colposcopically directed punch biopsy.
Cervical histology
It can be seen from Table III that five (19%) lymphoma
patients had CIN II/III, compared with two (3%) of the
controls. This difference is statistically significant (P<0.01)
by the x2 test. The percentages of lymphoma patients with
koilocytosis alone, and with CIN I, were not significantly
greater than the percentages of control patients with these
abnormalities. Significantly more lymphoma patients (14
patients, 52%) had evidence of cervical HPV infection than
controls (21 patients, 27%, P<0.02). Table II shows that all
six lymphoma patients with CIN were HD patients. The
proportion of HD patients with CIN (32%) was not,
however, significantly different from the proportion of non-
Hodgkin's lymphoma patients with CIN (0%) (P>0.05) by
Fisher's exact probability test.
Table IV shows that the lymphoma patients with cervical
koilocytosis without CIN were older, more likely to be
parous and became sexually active rather later than the
patients in whom no significant abnormality was detected.
They also had had their lymphomas diagnosed for longer
periods. Lymphoma patients with CIN, on the other hand,
were younger, commenced sexual activity earlier and
reported more sexual partners than did the patients in whom
no abnormality was detected, although these differences were
not statistically significant (0.1>P>0.05 by Mann-Whitney
U test). Lymphomas had been diagnosed in these patients
Table III Cervical histology of patients and controls
Cervical Controls Lymphoma patients
histology (n= 79) (%) (n=27) (%)
No significant 57 (72) 13 (48)
abnormality
detected
Koilocytosis only 14 (18) 8 (30) NS
CIN Ia 6 (8) 1 (3) NS
CIN II/IIIH 2 (3) 5 (I9)b
Koilocytosis alone 21 (27) 14 (52)C
or in association
with CIN
aKoilocytes were seen in association with CIN in all cases except
one control patient with CIN I; bX2 =8.33 P<0.01 (lymphoma
patients versus controls); CX2 =5.8 P<0.02 (lymphoma patients
versus controls); NS=not significant.598 R.G. HUGHES et al.
Table IV Lymphoma patients' characteristics (grouped according to cervical histology and cytology)
Months since
Mean age at Median no. sexual diagnosis
Age Number coitarche partners Current smokers mean
(range) parous (%) (range) (range) (%) (range)
No significant 38.8 7 (54) 20.7 1 4 (31%) 41.1
abnormality (26-56) (13-40) (1-30) (8-97)
detected or
inflammation
alone
(n= 13)
Koilocytosis 43.5 6 (75) 23 1.5 2 (25%) 57.8
alone (32-59) (19-33) (1-8) (18-72)
(n=8)
CIN 32.6 3 (50) 18.7 4 0 39
(n=6) (24-47) (16-20) (1-9) (15-66)
before colposcopic examination for approximately the same
length of time as in the lymphoma patients with normal
cervices.
Discussion
We have demonstrated a significantly higher prevalence of
CIN II and III in lymphoma patients than in a control
group of women. Ideally each case should have been com-
pared with two or three controls, matched with the case for
known risk factors. However, colposcopic examination and
biopsy is an invasive procedure and, when carried out on
patients anaesthetised for dilatation and curettage or laparo-
scopic sterilisation, significantly increases the duration of the
general anaesthetic. The recruitment and examination of the
much larger number of controls necessary for this approach
would have presented considerable practical problems and it
was therefore decided that it was justifiable to compare
lymphoma patients with available controls, matched only for
age and oral contraceptive use. In fact the control patients
reported on average more sexual partners and an earlier
coitarche and were more likely to smoke than the lymphoma
patients (see Table I). A higher prevalence of CIN in the
controls than in the lymphoma patients would be predicted
on the basis of these known risk factors (La Vecchia, 1985;
Winkelstein et al., 1984). However, the reverse was found,
that is a significantly higher prevalence of CIN II and III in
lymphoma patients than in controls. This lends strong
support to our contention that lymphoma patients are at
increased risk of developing CIN, independent of known risk
factors such as sexual behaviour and smoking. It is note-
worthy that the lymphoma patients found to have CIN
reported having had more sexual partners than did either the
lymphoma patients without CIN or the normal controls (see
Tables I and IV).
The malignant potential of CIN II and III is well defined
with few cases regressing. The natural history of CIN I, on
the other hand, is still controversial (Campion et al., 1986)
as studies relying on cytology alone have tended to underes-
timate the severity of the initial lesion while those employing
colposcopic punch biopsy have found this procedure to be
curative in some cases, thus artificially increasing the 'regres-
sion' rate (Koss, 1978). In view of this uncertainty, patients
and controls with CIN I were separated from those with
CIN II and III for the purpose of statistical analysis.
The increased prevalence of CIN in lymphoma patients is
in agreement with the increase in other malignancies seen in
these patients (Coleman et al., 1982; Tester et al., 1984) and
may be due to immunosuppression. Five of the six lym-
phoma patients with CIN had received chemotherapy, which
contributes to immunosuppression in these patients (Schilsky
& Erlichman, 1982). It should, however, be remembered that
patients receiving chemotherapy tend to have more extensive
disease so that the apparent association between CIN and
chemotherapy may be due to the immunosuppressive effects
of the disease rather than the effects of chemotherapy. We
plan to explore this question further by studying breast
cancer patients treated with alkylating agents in an attempt
to separate the effects of these agents from the effects of the
lymphoma.
It is interesting that no CIN was detected in non-
Hodgkin's lymphoma patients treated with chemotherapy.
Less is known of the risk of second malignancies in non-
Hodgkin's lymphomas than in HD but the risk of acute
myeloid leukaemia in patients treated with alkylating agents
for non-Hodgkin's lymphoma appears to be similar to the
risk seen in HD patients treated with these agents (Pedersen-
Bjergaard et al., 1985). In this study there were only four
patients with non-Hodgkin's lymphomas who received che-
motherapy so that no firm conclusions can be drawn.
Of the six lymphoma patients with CIN, five had had
cervical smears performed within the preceding 4 years, but
only one of these smears was reported, on routine screening,
to be abnormal. When smears were taken under optimal
conditions at colposcopy and examined carefully three of six
cases of CIN were still undetected. This is consistent with the
published work of Giles et al. (1988) who studied 200
normal women and found that 22 (11%) had CIN; cervical
cytology failed to detect seven (32%) of these cases.
The strong association between cervical HPV infection and
cervical neoplasia is well recognised but whether the associa-
tion is causal or casual is not known (Anonymous, 1985a).
In this study 52% of lymphoma patients had cytological
and/or histological evidence of cervical HPV infection, alone
or in association with CIN. This was significantly higher
than the proportion of control patients with cervical HPV
infection (see Table III). However, it should be noted that
the lymphoma patients with koilocytosis only, in the absence
of CIN were, on average, 11 years older than those with
CIN and had been sexually active for 6.6 years longer than
CIN patients (see Table IV). The 'koilocytosis only' patients
had suffered from their lymphomas for longer than the CIN
patients (i.e. 57.8 months before colposcopy versus 39
months). These data tend to argue against HPV infection
being a premalignant condition and certainly demonstrate
that, even in immunosuppressed women, neoplastic change
does not inevitably follow. Other factors, including the
degree of immunosuppression and the carcinogenic potential
of chemotherapeutic agents given, as well as recognised risk
factors such as early onset of sexual activity and multiple
partners, are likely to be implicated.
We wish to thank Dr C.A. Ludlam for his cooperation in allowing
us to study patients under his care, and Dr E. McGoogan for
helpful discussions. We are grateful to the staff of the Lothian area
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